ConductScience.org, home

Paper489491

The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.

Collins P and 1 other. J Antimicrob Chemother, 1979. Cited by 106 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent. Papers, record 489491. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/489491

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.
PubMed
Journal
J Antimicrob Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
106
iCite
Relative citation ratio, by iCite
4.67
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Collins PP
2Bauer DJD J

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
GuanineMajor topic
HerpesviridaeMajor topic
Cell Survival
Viral Plaque Assay

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.

PMIDTitleJournalYearIn PapersSource
39165990Convenient screening of the reproductive toxicity of favipiravir and antiviral drugs in Caenorhabditis elegans.Heliyon2024https://conductscience.org/library/papers/39165990PubMed
21234082Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal.Can Fam Physician1991https://conductscience.org/library/papers/21234082PubMed
9661001Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9661001PubMed
8032338Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.Pharm World Sci1994https://conductscience.org/library/papers/8032338PubMed
7425614Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7425614PubMed
7103443Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7103443PubMed
7081975Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7081975PubMed
6785059Aciclovir and trifluorothymidine in herpetic keratitis. Preliminary report of a multicentered trial.Doc Ophthalmol1981https://conductscience.org/library/papers/6785059PubMed
6342900Clinical pharmacokinetics of acyclovir.Clin Pharmacokinet1983https://conductscience.org/library/papers/6342900PubMed
6321799Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.J Virol1984https://conductscience.org/library/papers/6321799PubMed
6315332Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.Drugs1983https://conductscience.org/library/papers/6315332PubMed
6314886Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6314886PubMed
6289962Acyclovir.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6289962PubMed
6284470Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.Drugs1982https://conductscience.org/library/papers/6284470PubMed
6282214Comparative efficacy of antiherpes drugs in different cell lines.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6282214PubMed
6282196Metabolism of acyclovir in virus-infected and uninfected cells.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6282196PubMed
6275786Virus inhibition assay for measurement of acyclovir levels in human plasma and urine.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6275786PubMed
6252836In vitro susceptibility of varicella-zoster virus to acyclovir.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252836PubMed
6246281Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.J Virol1980https://conductscience.org/library/papers/6246281PubMed
2825622Treatment of experimental cytomegalovirus infections with acyclovir.Arch Virol1987https://conductscience.org/library/papers/2825622PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/489491

GET https://conductscience.org/api/papers/v1/489491/cited_by?page=2